BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28935563)

  • 1. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
    Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
    Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
    Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
    Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation.
    Zheng M; Zhu Z; Zhao Y; Yao D; Wu M; Sun G
    Mol Med Rep; 2017 Jan; 15(1):375-379. PubMed ID: 27959435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
    Jiang JH; Pi J; Jin H; Cai JY
    J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oridonin inhibits BxPC-3 cell growth through cell apoptosis.
    Xu B; Shen W; Liu X; Zhang T; Ren J; Fan Y; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):164-73. PubMed ID: 25651847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
    Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
    Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5.
    Wu J; Ding Y; Chen CH; Zhou Z; Ding C; Chen H; Zhou J; Chen C
    Cancer Lett; 2016 Oct; 380(2):393-402. PubMed ID: 27387452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells.
    Gao S; Tan H; Zhu N; Gao H; Lv C; Gang J; Ji Y
    Int J Oncol; 2016 Jun; 48(6):2453-60. PubMed ID: 27082253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.
    Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL
    Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
    Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B
    Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways.
    Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW
    Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line.
    Qi X; Zhang D; Xu X; Feng F; Ren G; Chu Q; Zhang Q; Tian K
    Int J Nanomedicine; 2012; 7():1793-804. PubMed ID: 22619528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furano-1,2-Naphthoquinone Inhibits Src and PI3K/Akt Signaling Pathways in Ca9-22 Human Oral Squamous Carcinoma Cells.
    Lin KL; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
    Integr Cancer Ther; 2014 May; 13(3):NP18-28. PubMed ID: 22505597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
    Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
    Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.
    Wang HY; Zhang Y; Zhou Y; Lu YY; Wang WF; Xin M; Guo XL
    Biomed Pharmacother; 2016 Oct; 83():349-361. PubMed ID: 27416556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest.
    Yu XD; Yang JL; Zhang WL; Liu DX
    Tumour Biol; 2016 Mar; 37(3):2871-7. PubMed ID: 26409447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
    Hsieh TC; Wijeratne EK; Liang JY; Gunatilaka AL; Wu JM
    Biochem Biophys Res Commun; 2005 Nov; 337(1):224-31. PubMed ID: 16176802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
    Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
    Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
    Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
    Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
    Bao R; Shu Y; Wu X; Weng H; Ding Q; Cao Y; Li M; Mu J; Wu W; Ding Q; Tan Z; Liu T; Jiang L; Hu Y; Gu J; Liu Y
    BMC Cancer; 2014 Mar; 14():217. PubMed ID: 24655726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.